Mr Philippe Moingeon | Vice President of Research and Development
Stallergenes
SHORT PROFILE DESCRIPTION
PhD in Immunology, MBA, former Assistant Professor (Harvard Medical School, Boston, USA).
25 years of experience in the vaccine industry.
Currently, Vice President Research and Pharmaceutical Development and member of the Executive Committee (Stallergenes, Paris France).
EDUCATION
1998-2001 MBA (majors in Technology Management and Finance), Open University Business
School (Newcastle, UK).
- Post-doctoral fellow, Instructor, and Assistant Professor, Department of Pathology, Harvard Medical School, Boston, USA.
1981-1986 Resident of Paris Hospitals (« ancien interne des hôpitaux de Paris »).
1980 National Diploma of Pharmacist / Clinical Biologist, University of Pharmacy, Rouen, France.
PROFESSIONAL EXPERIENCE
Stallergenes SA (2003-present)
Vice President, Research and Pharmaceutical Development and member of Executive Committee.
Aventis Pasteur, formerly Pasteur Mérieux Connaught, 1994-2003
Director for the Cancer Vaccine Program, Director for external R and D, and General Secretary for Corporate R and D Department .
Academic research (1982-1994)
PhD student and resident at Institut Gustave Roussy, Department of Clinical Biology, Villejuif for 6 years.
Post-doctoral experience as Research Fellow (1987-1988), Instructor (1988-1990), Assistant Professor (1991-1994) in Laboratory of Immunobiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
21 patents/ patent applications and 180 scientific publications.
Fields of interest: human immunology, prophylactic and therapeutic vaccines against infectious diseases, cancers, allergies, development of biologicals.
back to speakers
Co-located with Biomarkers World Europe:
